The effect of probiotic supplementation on metabolic health in women with polycystic ovary syndrome

Investigating the Effect of Probiotic Supplementation on Hormonal and Metabolic Profiles in Women with Polycystic Ovarian Syndrome

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20250523065854N1

Enrollment

Registered

2025-07-16

Start date

2025-07-06

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polys cystic Ovary Syndrome.

Interventions

Intervention 1: For patients with polycystic ovary syndrome, the probiotic capsule Bilion3 CFU is prescribed twice a day for 12 weeks. The capsules contain 6 strains of probiotic bacteria (Bacillus co

Eligibility

Sex/Gender

Female

Age

18 Years to 49 Years

Inclusion criteria

Inclusion criteria: Participants will be women of reproductive age with a diagnosis of polycystic ovary syndrome based on the Rotterdam criteria, who are not currently using hormonal contraceptives or other medications that may affect hormone levels.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Sex hormones. Timepoint: At the beginning of the study (before the start of the intervention) and 12 weeks after supplementation. Method of measurement: Sex Hormones kit.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahsa malekian

Tabriz University of Medical Sciences

Dr.malekian@yahoo.com+98 41 3638 5801

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026